Our immunohistochemistry studies confirmed that PD-L1 is expressed both in tumor and infiltrating cells, while CTLA-4, PD-1, PD-L1, TIM-3, TIGIT, and VISTA were identified in infiltrating cells, both intratumorally and peritumorally. The gene discussed is HAVCR2; the disease is neoplasm.